Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Intomics expands client portfolio

publication date: Jul 4, 2011
 | 
author/source: Intomics
intomicsIntomics and AstraZeneca partner to accelerate drug discovery initiatives through data mining. AstraZeneca's knowledge within a range of diseases will be combined with Intomics' unique data analysis services to improve drug discovery projects.

AstraZeneca and Intomics have signed an agreement to accelerate drug discovery programs via Intomics' advanced, tailor-made solutions. With the collaboration announced today, AstraZeneca gains access to Intomics' pioneering knowledge discovery capabilities as well as leading expertise within the fields of biological data analysis, bioinformatics and systems biology. Intomics is going to assists in drug discovery projects by providing data, methods, and tools for integrating and analysing highly complex proprietary clinical, biological and chemical data. The collaboration spans a range of research projects. The financial terms of the agreement were not disclosed.

"We are delighted to assist AstraZeneca with their very exciting research projects. We see a great synergy in combining our data analysis expertise with AstraZeneca's profound knowledge in some very important disease areas.  The collaboration will help facilitate efficient drug discovery projects with shorter turnaround time and improved results," says Thomas S. Jensen, CEO of Intomics. He continues, "With the huge amount of data generated in today's research projects, access to leading data analysis capabilities becomes key, and we are pleased that AstraZeneca, one of the largest pharmaceutical companies in the world, has recognized our expertise within the field." 

About Intomics

Intomics is a contract research company with leading expertise in biological data analysis & data mining, bioinformatics and systems biology. Using pioneering technologies, Intomics provide tailored solutions leading to increased success rates and cost savings in pharmaceutical research projects. For more information, please contact Thomas S. Jensen, CEO Intomics A/S, p:+45 8880 7979, e: skot@intomics.com, w: http://www.intomics.com 


 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events